Key facts
- Nortian’s last known valuation is $100.0M (May 2025).
- It has raised $41.0M; the latest was Early Stage VC ($41.0M) in May 2025.
- Notable investors include AJHollander, Integrated Proteins (Missouri ).
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Nortian
- ·The full record, as it builds
Funding rounds
No funding rounds for Nortian are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Nortian
Operator of a biotech company intended to produce ultra-pure collagen from hide through a proprietary, vertically integrated process. The company offers supplements, food, and pharmaceutical products, and its ingredients meet the standards of purity and performance, and its proprietary process transforms hides, typically discarded in the meat industry, into highly purified collagen, enabling producers to create a scalable model for upcycling animal byproducts into high-value ingredients.
- Sector
- Healthcare
- HQ
- Kansas City, MO, United States
- Founded
- 2024
- Website
- nortian.com/
- Ownership
- Privately Held (backing)
Nortian doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Nortian shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Nortian in its N-PORT filings yet. We sweep new filings monthly.